Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Global Change Biology
|
April 7, 2023
Tracing the future of epidemics: Coincident niche distribution of host animals and disease incidence revealed climate-correlated risk shifts of main zoonotic diseases in China
Bo Cao, Chengke Bai, Kunyi Wu, et al.
Annals of Hematology
|
June 3, 2019
The abnormal function of CD39<sup>+</sup> regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopenia
Yumeng Lu, Luya Cheng, Feng Li, et al.
Plant, Cell & Environment
|
September 11, 2025
The Transcription Factor MYB8 Positively Regulates Flavonoid Biosynthesis of Scutellaria baicalensis in Response to Drought Stress
Chong Chen, Xiaofang Zhou, Bo Cao, et al.
Cancer Medicine
|
November 9, 2023
TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage
Shuaikang Chang, Wenqin Xiao, Yongsheng Xie, et al.
Acta Biochimica Et Biophysica Sinica
|
April 6, 2021
Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3K‒AKT‒mTOR/JNK pathway
Ke Hu, Bo Li, Ruye Ma, et al.
Neoplasia (New York, N.Y.)
|
December 10, 2021
DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway
Shuaikang Chang, Bo Li, Yongsheng Xie, et al.
International Immunopharmacology
|
December 29, 2023
A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatory
Hui Zhang, Ke Hu, Yumeng Lu, et al.
International Immunopharmacology
|
November 1, 2023
Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells
Qilin Feng, Ke Hu, Huifang Hu, et al.
International Immunopharmacology
|
June 22, 2024
Corrigendum to "Berberine derivative DCZ0358 induced oxidative damage by ROS-mediated JNK signaling in DLBCL cells" [Int. Immunopharmacol. 125(Part A) (2023) 111139]
Qilin Feng, Ke Hu, Huifang Hu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 11, 2020
A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe
Liangning Hu, Bo Li, Gege Chen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Global Change Biology
|
April 7, 2023
Tracing the future of epidemics: Coincident niche distribution of host animals and disease incidence revealed climate-correlated risk shifts of main zoonotic diseases in China
Bo Cao, Chengke Bai, Kunyi Wu, et al.
Annals of Hematology
|
June 3, 2019
The abnormal function of CD39<sup>+</sup> regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopenia
Yumeng Lu, Luya Cheng, Feng Li, et al.
Plant, Cell & Environment
|
September 11, 2025
The Transcription Factor MYB8 Positively Regulates Flavonoid Biosynthesis of Scutellaria baicalensis in Response to Drought Stress
Chong Chen, Xiaofang Zhou, Bo Cao, et al.
Cancer Medicine
|
November 9, 2023
TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage
Shuaikang Chang, Wenqin Xiao, Yongsheng Xie, et al.
Acta Biochimica Et Biophysica Sinica
|
April 6, 2021
Anti-DLBCL efficacy of DCZ0825 in vitro and in vivo: involvement of the PI3K‒AKT‒mTOR/JNK pathway
Ke Hu, Bo Li, Ruye Ma, et al.
Neoplasia (New York, N.Y.)
|
December 10, 2021
DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway
Shuaikang Chang, Bo Li, Yongsheng Xie, et al.
International Immunopharmacology
|
December 29, 2023
A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatory
Hui Zhang, Ke Hu, Yumeng Lu, et al.
International Immunopharmacology
|
November 1, 2023
Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells
Qilin Feng, Ke Hu, Huifang Hu, et al.
International Immunopharmacology
|
June 22, 2024
Corrigendum to "Berberine derivative DCZ0358 induced oxidative damage by ROS-mediated JNK signaling in DLBCL cells" [Int. Immunopharmacol. 125(Part A) (2023) 111139]
Qilin Feng, Ke Hu, Huifang Hu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 11, 2020
A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe
Liangning Hu, Bo Li, Gege Chen, et al.
Page
of 3